Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:ACOR
Tag: NASDAQ:ACOR
Acorda Therapeutics Inc (NASDAQ:ACOR) gets downgraded to Underweight by JPMorgan Chase...
ME Staff
-
October 24, 2019
0
Acorda Therapeutics Inc (NASDAQ:ACOR) gets downgraded to Neutral by HC Wainwright...
ME Staff
-
August 14, 2019
0
Acorda Therapeutics, Inc. (NASDAQ:ACOR) Files An 8-K Submission of Matters to...
ME Staff 8-k
-
June 20, 2019
0
Acorda Therapeutics,Inc. (NASDAQ:ACOR) Files An 8-K Departure of Directors or Certain...
ME Staff 8-k
-
March 8, 2019
0
Acorda Therapeutics Inc (NASDAQ:ACOR) had its Hold rating reiterated by Cantor...
ME Staff
-
February 15, 2019
0
Acorda Therapeutics,Inc. (NASDAQ:ACOR) Files An 8-K Departure of Directors or Certain...
ME Staff 8-k
-
January 28, 2019
0
Acorda Therapeutics,Inc. (NASDAQ:ACOR) Files An 8-K Other Events
ME Staff 8-k
-
January 18, 2019
0
Acorda Therapeutics Inc (NASDAQ:ACOR) price target set to $18.00 by Oppenheimer
ME Staff
-
January 2, 2019
0
Acorda Therapeutics Inc (NASDAQ:ACOR) had its Neutral ➝ Hold rating reiterated...
ME Staff
-
December 26, 2018
0
Acorda Therapeutics,Inc. (NASDAQ:ACOR) Files An 8-K Other Events
ME Staff 8-k
-
December 26, 2018
0
1
2
3
...
8
Page 1 of 8
